Montreux Equity Partners
   
 

Latest News

June 22, 2009
NeurogesX and Astellas Enter Commercialization Agreement for Qutenza™

June 10, 2009
Bayhill Therapeutics Enters Exclusive, Worldwide Collaboration with Genentech for BHT-3021 in Type 1 Diabetes

May 11, 2009
SkinMedica to Co-promote ACZONE® (dapsone) Gel 5% to Pediatricians in the U.S.



Action. Experience. Collaboration.

Montreux Equity Partners is a life sciences venture capital firm focused on building great pharmaceutical and medical device companies. Montreux's goal is to generate significant returns by investing in superior businesses with high quality management teams.

Montreux seeks investment opportunities in which it can add value beyond the commitment of capital. Montreux works with entrepreneurs and management teams who wish to operate in a dynamic partnership based on shared interests and common goals. Montreux's operating philosophy is anchored in a foundation of honesty, integrity, and uncompromising professionalism.

NVCA Member

©2009 Montreux Equity Partners. All Rights Reserved.